Recruiting now—Ages 50 Years and up
Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas
Sponsor: Leiden University Medical Center · NCT04832620 on ClinicalTrials.gov ↗
Conditions studied
Bone Neoplasm of Vertebral ColumnChordomaChondrosarcomaMagnetic Resonance ImagingPET-CTProton Therapy
Where it's running2 sites
2 international sites
- Recruiting now
HollandPTC
Delft, South Holland, Netherlands 2629 JH
- Stijn Krol, MD PhD(contact)+31624539398[email protected]
- Charlotte van der Vos, PhD(contact)+31885011186[email protected]
- Stijn Krol, MD PhD(principal investigator)
- Recruiting now
LUMC
Leiden, South Holland, Netherlands 2333 ZA
- Stijn Krol, MD PhD(contact)+31624539398[email protected]
- Vesna Miladinovic(contact)+31682225869[email protected]
- Hans Bloem, prof. MD PhD(principal investigator)
- Stijn Krol, MD PhD(sub investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Histologically diagnosed with primary or recurrent chordoma or chondrosarcoma in the axial skeleton (clivus, spine and sacrum) * Accepted for standard proton beam therapy Exclusion Criteria: * Diagnosis other than chordoma or chondrosarcoma is made. * Patient refuses (parts) of the standard treatment protocol. * Patient refuses MRI due to claustrophobia. * Patient not suitable for MRI due to the presence of MRI incompatible implants. * Incapacitated patients. * Patient doesn't allow coded data to be used for analysis. * Patient is under 50 years of age. * Lesion size less than 1cm. * Patients with WHO 3 and higher.
Updated 2023-11-18 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.